Upload
guillem-llorens-blanch-phd
View
106
Download
0
Embed Size (px)
Citation preview
REMOVAL OF PHARMACEUTICALS FROM WWTP STREAMS BY BIOLOGICAL AND PHYSICAL
PROCESSES
Guillem Llorens Blanch November 3th, 2016
! Content
1. Introduc>on 2. Objec>ves 3. Removal of pharmaceu>cal products by
solid-‐state fermenta>on 4. Removal of pharmaceu>cals in bioslurry
systems 5. Post-‐treatment of WWTP effluent 6. Concluding Remarks
!
INTRODUCTION
!
INTRODUCTION
1. Emerging Pollutants 2. Bioremedia>on 3. Removal techniques
!
INTRODUCTION
Water pollu4on The introduc>on of a foreign substance that leads to…
Quality lost Threat for the environment and the health
Common diseases of water pollu>on: – Waterborne diseases – Metal poisoning – Reproduc>ve altera>ons – Cancer
EMERGING POLLUTANTS
!
INTRODUCTION
Emerging Pollutants (EPs) Synthe>c and natural products Heterogenic group Not yet regulated Detected in salt-‐water, freshwater, wastewater, sludges and soils
Few ng·∙L-‐1 to thousands µg·∙L-‐1 Not clearly classificated
EMERGING POLLUTANTS
!
INTRODUCTION
EPs classifica4on EMERGING POLLUTANTS
Group Abbrevia4on Observa4ons
Pharmaceu>cal products PhACs Prescribed and non-‐prescribed drugs & drug abuse substances
Personal care products PCPs Cosme>c and personal hygiene products
Endocrine-‐disrup>ng chemicals EDCs Natural & synthe>c chemicals
Halogenated compounds PFCs Surfactants, lubricants, paints & fire retardants
Pharmaceu>cal and personal care products
PPCPs PhACs + PCPs
Transforma>on products TPs PPCPs transformed in WWTPs
!
INTRODUCTION
Fate and distribu4on Different from one country to another Depends on the… – Produc>on – Consump>on
EPs reach the environment through…
EMERGING POLLUTANTS
Seasonal fluctua>ons
Smart, J.; 9 ways guys pee
!
INTRODUCTION
EPs in WWTPs Plants designed to remove organic maaer, nutrients, SS, metals and pathogens EPs goes through the treatment without relevant concentra>on’s decrease
Why is that happening?
EMERGING POLLUTANTS
!
INTRODUCTION
EPs in WWTPs Not tradi>onally considered as pollutants Low concentra>ons Wide heterogenic group Seasonal fluctua>ons Detected in all environmental compartments
EMERGING POLLUTANTS
!
INTRODUCTION
EPs in WWTPs. Who does EPs affect the environment? EMERGING POLLUTANTS
.
. .
EPs pollu>on
WWTP Opera>onal
Consump>on
Hydrophobicity
Infiltra>ons
Sludge
Leachates
!
INTRODUCTION
EPs in WWTPs. Valorisa4on of sewage sludge EMERGING POLLUTANTS
Anaerobic Diges>on
Biogas
Digestate
Liquid liquor
Compos>ng Compost
Land applica>on
Sludge
40% – 60% of OM CH4 (60-‐65%) + CO2 (30-‐35%)
Stable, nutrients rich & pathogen
free
Nutrients, structure, water infiltra>on, porosity & erosion
!
INTRODUCTION
EMERGING POLLUTANTS
Wastewater
WT
Consump>on
Sludge Condi>oning
Soil
WWTP EPs
Hydrophilic EPs
Natural
water bodies
Hydrophobic EPs
!
INTRODUCTION
Bioremedia4on Elimina>on of pollutants through microorganisms In contrast to physical & chemical processes: - Higher opera>onal >mes - Lower inputs
Can be performed in situ o ex situ Factors: energy source, environmental factors, bioavailability and bioac>vity
BIOREMEDIATION
, what is it?
!
INTRODUCTION
Strategies BIOREMEDIATION
Natural aSenua4on Bios4mula4on Bioaugmenta4on
Who? Authochthonous Authochthonous Foreign microorganism
What is supplied?
Nothing (monitoring)
Bulking material, water, nutrients and/or aera>on
Microorganism + bulking material, water, nutrients and/or aera>on
!
INTRODUCTION
Fungal remedia4on 1980s: White-‐rot Fungi (WRF) - Basidiomycetes - Filamentous fungi - Wood decomposers
Mineralisa>on and depolymerisa>on of lignin: - Extracellular enzyma>c system (LMEs) - Intracellular enzyma>c system (Cytochrome P-‐450)
BIOREMEDIATION
!
INTRODUCTION
Trametes versicolor Widely distributed in the environment Able to growth in solid & liquid cultures Extracellular enzyma>c system with high red-‐ox capacity: MnP, LiP and Laccase
Intracellular enzyma>c system: Cytochrome P450
BIOREMEDIATION
!
INTRODUCTION
BIOREMEDIATION
Trametes versicolor
Liquid matrix
Effluents treatment
Solid matrix
Sludge and soil
treatment
Synthe>c dyes
Pharmaceu>cals and Personal Care Products
(PPCPs)
Endocrine-‐Disrup>ng Chemicals (EDCs)
Polycyclic Aroma>c Hydrocarbons (PAHs)
Brominated flame
retardants
Chlorinated solvents (PCE, TCE)
Air pulsed fluidized bed
Biopile (up) and bioslurry (down)
!
INTRODUCTION
Removal techniques for EPs WWTPs effluents will be used for further applica>ons, its necessary to remove EPs
REMOVAL TECHNIQUES
Fungal bioremedia>on, due to its performance, can by used: - For low volumes/flows - Where is produced (in situ) or specific streams of
WWTPs For higher volumes/flows physical
process
!
INTRODUCTION
Removal techniques for EPs WWTPs effluents will be used for further applica>ons, its necessary to remove EPs
REMOVAL TECHNIQUES
Sludge
Water
Water
Slurry-‐phase bioreactor
Solid-‐phase bioreactor
Liquid effluent Adsorp>on
!
INTRODUCTION
Slurry-‐phase bioreactor Also known as bioslurry For pollutants absorbed in solid par>cles Ex situ, reactor: - Suspension of a solid in water (5 – 40% w/v) - Agita>on - Aera>on
Indigenous microorganisms or inoculated Addi>on of: nutrients, neutralising agents, surfactants and/or co-‐metabolites
Monitored parameters: temperature, pH and dissolved oxygen
REMOVAL TECHNIQUES
!
INTRODUCTION
Solid-‐phase bioreactor Also known as biopiles Ex situ or in situ Engineered biological process in order to mineralise pollutants - Sludge mixed with bulking material - Complementary systems: aera>on, irriga>on and leachate collector
- Monitored parameters: moisture, pH, heat, nutrients and oxygen
Low inputs and maintenance (cost-‐effec>ve)
REMOVAL TECHNIQUES
!
INTRODUCTION
Adsorp4on techniques Removal of organic and inorganic pollutants In situ or ex situ Adsorbents can be natural or synthe>c Surface phenomenon: liquid that contains a solute contacts a porous solid
Solutes retained in the porous by liquid-‐solid intermolecular aarac>on forces: - Electrosta>c aarac>on - Chemical mechanisms - Physical mechanisms
REMOVAL TECHNIQUES
!
OBJECTIVES
!
OBJECTIVES
AIM…
to develop novel biological and physical processes to remove PPCPs in different streams
of WWTPs
!
OBJECTIVES
HOW? Finding the best condi>ons to colonize sewage sludge by
Trametes versicolor using lignocellulosic substrate Assessing the strategies to remove PhACs in bioslurry and
biopiles systems inoculated with Trametes versicolor under non-‐sterile condi>ons
Determining the applicability of the anaerobic diges>on as a valorisa>on method for the fungal biomass
Studdying the microbial communi>es evolu>on in fungal mediated biopiles
Inves>ga>ng the u>liza>on of low-‐cost sorbents to adsorb EPs as post-‐treatment of a WWTP’s effluent
! REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
1. Introduc>on 2. Methodology 3. Results
Total drugs removal Microbial community evolu>on
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
As previously men4oned… Sludge is an inevitable waste of any WWTP Valorised in order to improve agricultural soils (sludge as amendment)
Tradi>onal dewatering techniques and stabiliza>on methods do not remove all EPs
Must be treated before its applica>on
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Trea4ng sewage sludge Expensive & not efficient physicochemical processes has been proposed to remove EPs In contrast, fungal bioremedia>on: sustainable & economical - Fungi degrade a wide variety of compounds - Minimum maintenance - Low inputs
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Key role of substrate… Fungal colonisa>on depends on it Must act as bulking agent Extensively available Locally produced
Economical & sustainable
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Agro-‐industrial waste
Forestry by-‐products Valorised waste
What is it? Residues from
growing, processing & trea>ng food
Non-‐commercial wood by-‐products
Green waste: food & small-‐size plant
wastes
Useful because of… OM (BOD & COD) Structure & lignin Nutrients, OM &
lignin
Examples: Palm fiber, seeds & shells, brewery & fish
ac>vi>es
Sawmill, sawdust, trimmings & bark Compost
When used as substrate…
LMEs Removals Structure
LMEs Removals Structure
LMEs ≈ Removals Structure
Agro-‐industrial waste
Forestry by-‐products
What is it? Residues from
growing, processing & trea>ng food
Non-‐commercial wood by-‐products
Useful because of… OM (BOD & COD) Structure & lignin
Examples: Palm fiber, seeds & shells, brewery & fish
ac>vi>es
Sawmill, sawdust, trimmings & bark
When used as substrate…
LMEs Removals Structure
LMEs Removals Structure
Agro-‐industrial waste
What is it? Residues from
growing, processing & trea>ng food
Useful because of… OM (BOD & COD)
Examples: Palm fiber, seeds & shells, brewery & fish
ac>vi>es
When used as substrate…
LMEs Removals Structure
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Different substrates can be used for fungal biopiles… but not all work as bulking material According to previous studies & to Valen>n et al. (2009): pine bark as substrate
Bark of Pinus halepensis: - The most common tree in Catalonia - The lowest economical value
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
The WWTP of El Prat de Llobregat 419,000m3·∙d-‐1 wastewater 2,000,000 equivalent popula>on
INTRODUCTION
Polymers
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Aim… Rodríguez-‐Rodríguez (2014) treated dry sludge in biopiles with a non-‐scalable bulking material:
wheat straw Determine if WWTP sludge could be treated in
fungal biopiles systems with inexpensive lignocellulosic substrate
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
METHODOLOGY
PPPCs at real concentra>ons
SUSBTRATE
DRY SLUDGE
Trametes versicolor
Total PPCPs removal
Laccase ac>vity
Microbial community
0 – 22 days
23 – 42 days
Triplicates &
Sta>s>c analysis
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Biopile systems Pre-‐grown fungus onto sterile pine barks (7d) + non-‐sterile dry sewage sludge Enzyma>c Ac>vity: oxida>ve state of T.versicolor
Drugs concentra>on: removal capaci>es Microbial iden>fica>on: communi>es dinamics
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Maximum enzyma>c ac>vity by day 10: 0.007±0.002 U·∙g-‐1 Compared to other substrates: lower degradability
Degrada>on pathway involves: metabolism, co-‐metabolism & detoxifica>on mechanisms
RESULTS
ENZYMATIC ACTIVITY
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
RESULTS
TOTAL DRUGS REMOVAL
!"#$%#&'()*&#+,-.*)*#+,
&/.&'.)$#)*/.,0,123,4.565789,
1'%/:#+;,4<9,0,23,!"#$%"&%"'
()$*+,-.($)&/0012&3$)'%"'
()$*+,-."1&/4012&5"'()$*+,-."1&
/4012&
=.#+5';*&;,#.>,#.)*7*.?+#%%#)/$@,>$(5;,!"#$ %&'()$ *$ %('+,$
#$ %-'(($ *$ .'%-$ (+'&/$ *$ .'(/$012345467$ -'-+$ *$ .')8$
#,%%')%$ *$ .'%8$ ,.'8&$ *$ %'..$
9457:67$ .'(-$ *$ .'88$#, .'..$ *$ .'..$ #$
=.)"'+%*.)*&,;7<=>:?4@$ +'&+$ *$ .'(+$ 88',,$ *$ .'8($ 8%'&.$ *$ .'88$ +,'.)$ *$ .'+,$
=.)*A*/)*&;,ABC$ /'-($ *$ .'&+$ ),'-)$ *$ %'..$ ),'-)$ *$ %'..$ ),'-)$ *$ %'..$
=.)*"@B'$)'.;*:',>$(5;,D>@45:E:67$ %)'%)$ *$ +'-($ -('-+$ *$ .'-($ -&'/)$ *$ .'+.$ )8',)$ *$ .')($
C#+&*(%,&"#..'+,A+/&D'$;,F:@G:=H7>$ /'&%$ *$ %'%,$ %..'..$ *$ %'..$ %..'..$ *$ %'..$ %..'..$ *$ %'..$
3*($')*&,IJK$ )'&)$ *$ .'%/$ -,'8+$ *$ .'-,$ )8'(.$ *$ &'%8$ )8'(.$ *$ &'%8$K=>?L@4?:6$ ,'.&$ *$ .'+%$ (%'&+$ *$ .'(8$ %+',%$ *$ .'%/$ +('&($ *$ .'+-$
E*B*>,$'5(+#)/$;,#.>,&"/+';)'$/+,+/F'$*.5,;)#)*.,>$(5;,M7>N:OP4H:@$ (/'+8$ *$ %%'(8$ /.',-$ *$ .'/%$ +-'.($ *$ .'+-$ /&'%($ *$ .'/&$DG4P<=?G=G:6$ 8.',&$ *$ ('8($ )('.%$ *$ .')($ ,+'--$ *$ .',+$ &(').$ *$ .',-$
!;@&"*#)$*&,>$(5;,9:G=@4EP=>$ ,+'++$ *$ %.'-/$ -8',/$ *$ .'-($ %&'/&$ *$ .'8.$ (+'-+$ *$ .'(+$A7PGP=@:67$ +8'+)$ *$ +'/&$ &8'&,$ *$ %'..$ &8'&,$ *$ %'..$ &8'&,$ *$ %'..$Q@L417G:67$ +%'%-$ *$ )'(&$ )%'+($ *$ .')8$ ,8',&$ *$ .',($ ,+'%/$ *$ .',+$R=P417G:67$ -8'%($ *$ +'+%$ ),'()$ *$ .'),$ ,&'(8$ *$ .',&$ ),'+,$ *$ .'))$KP=H45467$ (-'&%$ *$ +'&,$ ,+'..$ *$ .',+$ +(',&$ *$ .'+-$ )('))$ *$ .')-$S76@=N=1:67$ 8&'/-$ *$ %',8$ ('(-$ *$ .'.($ #$ %/'/&$ *$ .'%,$9"J$ +'.+$ *$ .'/&$
#, #,.'-8$ *$ .'..$
0@=6H=E:67$ -',&$ *$ %'(%$ %..'..$ *$ %'..$ %..'..$ *$ %'..$ %..'..$ *$ %'..$
K4G=@$ -(.',&$ *$ %.('8/$ +/')&$ *$ .'+,$ -&'%)$ *$ .'+8$ //'-+$ *$ .'&/$#$T7>4<=@$64G$=??7??75U$N:6=@$346376GP=G:46$V=?$W:XW7P$GW=6$GW7$:6:G:=@$
19 drugs at 0d 430.79 ± 103.26 ng·∙g-‐1
psychiatric drugs 8 compounds (42%) Amount: 295.79 ± 39.74 ng·∙g-‐1 (69%)
5 drugs Conjuga>on process
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
RESULTS
TOTAL DRUGS REMOVAL
Re-‐inoculated 144.51 ± 4.06 ng·∙g-‐1
66.45 ± 0.96 %
Non-‐re-‐inoculated 218.92 ± 49.71 ng·∙g-‐1
49.18 ± 0.52 %
Control 207.22 ± 47.15 ng·∙g-‐1
51.90 ± 0.54 %
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Microbial diversity in the biopiles system assessed by - PCR-‐DGGE fingerprints - Phylogene>c affilia>ons
Inoculated cultures: 0d, 10d, 22d, 23d & 42d Non-‐inoculated cultures: 0d, 22d & 42d
RESULTS
MICROBIAL COMMUNITY EVOLUTION
PCR-‐DGGE fingerprints of fungal popula4on
T.versicolor T.versicolor
PCR-‐DGGE fingerprins of bacterial popula4ons
Lysobacter spp.
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
RESULTS
MICROBIAL COMMUNITY EVOLUTION
Fungal community 11 different fungi detected Ini>al >me
- T.versicolor: predominant band (>99%) for inoculated biopiles - No predominant band for non-‐inoculated biopiles
Fungal community came from substrate 8 fungi reported to degrade EPs 4 fungi had mycosta>c capabili>es
Fungus Order Detected at 4mes (d)
Acremonium sp. Hypocreales 10
Pseudallescheria ellipsoidea Microascales 0
Peniophora cinerea Russulales 0
Rhodotorula mucilaginosa Sporidiobolales 0
Coriolopsis galica Polyporales 42
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
RESULTS
MICROBIAL COMMUNITY EVOLUTION
Fungal community 11 different fungi detected Ini>al >me
- T.versicolor: predominant band (>99%) for inoculated biopiles - No predominant band for non-‐inoculated biopiles
Fungal community came from substrate 8 fungi reported to degrade EPs 4 fungi had mycosta>c capabili>es
Fungus Order Detected at 4mes (d)
Trichosporon asahii Tremellales 22 & 42
Wickerhamomyces anomalus Saccharomycetales 42
Meyerozyma guilliermondii Saccharomycetales 22 & 42
Meyerozyma sp. Saccharomycetales 42
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Bacterial community 23 different bacteria detected Ini>al >me: organisms from Cloistridiales order (obligate anaerobes)
Predominant organism: Lysobacter sp. First days: 11 organisms from Bacillales order Final days: Lysobacter sp., Alcaligenes sp., Salinimicrobium sp., Pedobacter bauzanensis & Brevibacterium siliguriense
RESULTS
MICROBIAL COMMUNITY EVOLUTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
Global community Fungal & microbial communi>es disturbed by the inocula>on event Fungal community: - Inoculated: 3 prevalent species, 1 lignocellulosic decomposer, 2 with mycosta>c abili>es & all with pollutant removal abili>es
- Non-‐inoculated: 2 prevalent species, both with inhibitory systems & pollutant removal abili>es
Bacterial Community: - Disturbed adding bulking material, water & O2 - Similar evolu>on of inoculated & non-‐inoculated
RESULTS
MICROBIAL COMMUNITY EVOLUTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS BY SOLID-‐STATE FERMENTATION
T.versicolor improved the drugs removal from sewage sludge in biopiles systems with pine bark as substrate under non-‐sterile condi>ons
T.versicolor was s>ll in the biopiles (at least) un>l day 23
Fungus’ re-‐inocula>on led to improved removal rates
Addi>on of bulking material and fungus inoculum changed the microbial communi>es
Similar evolu>on for both inoculated and non-‐inoculated cultures
CONCLUSIONS
! REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
1. Introduc>on 2. Methodology 3. Results
T.versicolor in liquid cultures Bioslurry at Erlenmeyer scale Bioslurry at reactor scale
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Membrane Biological Reactor (MBR) MBR system combines a suspended biomass reactor with a filtra>on process (no need for a sealer) Interes>ng way to improve exis>ng WWTPs: technological improvement and cost reduc>on
High cellular reten>on >me and high biomass concentra>on: promotes the biodegrada>on of organic contaminants
Two configura>ons: - Internal/submerged configura>on - External/side-‐stream configura>on
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
WWTP of Terrassa Designed to treat 75,000 m3·∙d-‐1 of urban and industrial wastewater MBR with internal configura>on: - Q: 7,200m3·∙d-‐1
- TSS: 4-‐5 g·∙L-‐1
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Aim… Determine the capacity of Trametes versicolor to remove drugs from raw MBR sludge in
bioslurry systems Evaluate the valorisa4on of fungal bioslurry’s
solids in an anaerobic digester
INTRODUCTION
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
METHODOLOGY
T.v. in liquid cultures
T.v. in bioslurry at Erlenmeyer
scale
T.v. in bioslurry at reactor scale
Growth & removal
Laccase Glucose
HZT (10ppm)
9 days
Media effect & (non-‐)sterile condiNon
Laccase Glucose
HZT (10ppm)
10 days
Spiked drug
Drugs removal under non-‐
sterile condiNon
Laccase PPCPs μorgs
15 days
Non-‐spiked drugs
Bioreactor
Anaerobic Diges4on
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Liquid cultures
METHODOLOGY
100mL growing medium
Trametes versicolor 10ppm
HZT
130rpm / 25ºC / 9d
HZT quan>fica>on
Laccase ac>vity
Glucose consump>on
Triplicates &
Sta>s>c analysis
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Bioslurry in Erlenmeyer
METHODOLOGY
100mL
Trametes versicolor 10ppm
HZT Only for spiked
130rpm / 25ºC
HZT quan>fica>on
Laccase ac>vity
Glucose consump>on Spiked Cultures
Defined Glucose
No nutrients (sterile) No nutrients (non-‐sterile)
Non-‐spiked (No nutrients) sterile non-‐sterile PPCPs quan>fica>on
Microbial analysis
Triplicates &
Sta>s>c analysis
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Bioslurry at reactor scale
METHODOLOGY
Trametes versicolor 115rpm / 5d
PPCPs quan>fica>on
Laccase ac>vity
5L raw sludge
pH control
Anaerobic diges>on Triplicates
& Sta>s>c analysis
!
Anaerobic Diges4on: BMP Test
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
METHODOLOGY Anaerobic diges>on VT: 1L
VW: 0.6L [VS]: 3gVS·∙L-‐1
Sta>c Condi>ons 36ºC
Pressure increment
Biogas quan>fica>on
Triplicates &
Sta>s>c analysis
!
Anaerobic Diges4on: Inoculum selec4on
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
METHODOLOGY VT: 1L
VW: 0.6L [VS]: 1.5gVS·∙L-‐1
Sta>c Condi>ons 36ºC
Pressure increment
Biogas quan>fica>on
AD inoculums Terrassa Sabadell Blanes
4.0 gCOD-‐VFA·∙L-‐1 (C2:C3:C4= 73:21:04 gCOD) 2mL·∙L-‐1 nutrients pH = 7
Triplicates &
Sta>s>c analysis
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Liquid cultures Degrada>on experiments in spiked liquid medium cultures were carried out at op>mal T.versicolor growth condi>ons Assessment of fungus capacity to grow and remove spiked drugs in liquid medium - Spiked drug: Hydrochlorothiazide (HZT)
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Liquid cultures
RESULTS
Removed: 45% Adsorbed: 10% Degraded: 35%
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Spiked bioslurry Once the removal capaciPes of T.versicolor in
liquid medium were assessed… Determine the effect of media composi4on on the degrada>on of spiked HZT: - MBR sludge - 3 mediums: complete, glucose & no-‐nutrient - Sterile & non-‐sterile condi>ons
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
RESULTS
Spiked bioslurry
Medium Complete Glucose No-‐nutrient (sterile)
No-‐nutrient (non-‐sterile)
Raw sludge (non-‐sterile)
Laccase (max)
322 U·∙L-‐1 (4d)
198 U·∙L-‐1 (4d)
331 U·∙L-‐1 (4d)
0 n.a.
Removal 13.8 % 71.4 % 69.1 % 93.2 % 94.1 %
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Spiked bioslurry Medium affects the degrada>on of HZT
RESULTS
Parameter Value
pH 5.16
TSS (g·∙L-‐1) 3.98 ± 0.04
VSS (g·∙L-‐1) 2.43 ± 0.03
TC (mg·∙L-‐1) 181.789 ± 4.72
TOC (mg·∙L-‐1) 74.348 ± 5.20
TAN (mg·∙L-‐1) 42.9 ± 0.04
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Spiked bioslurry Medium affects the degrada>on of HZT HZT was degraded in all experimental cultures: - Highest rate systems without added nutrients
No-‐nutrient medium was selected for subsequent experiments
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Non-‐spiked bioslurry Once the operaPonal condiPons were selected… Non-‐spiked fungal bioslurry under non-‐sterile condi>ons at Erlenmeyer scale Assessment of fungus’ efficiency to eliminate PPCPs at real concentra4ons
Evaluate how the fungal inocula>on would affect the autochthonous microbial popula4on of the sludge
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
RESULTS
!"#$%#&'()*&#+,-.*)*#+,&/.&'.)$#)*/.,
0,,12,3.456789,
:'%/;#+,<*'+=>,3?9,@!
!"#$%&'()*+,-()./&)+$#"*/(/#"-0+
!"#$%&'()*+,"#"1-()./&)+$#"*/(/#"-0+
2#"1/"#$%&'()*+,"#"1-()./&)+$#"*/(/#"-0+
A.#+4'>*&>,#.=,#.)*7*.B+#%%#)/$<,=$(4>,
"#$! %&'()! *! +(,! -+()!*!-(%! .'(.!*!-(%! #,
$/0123410! ''(,! *! 5()! 56(,!*!%(%! #, #,
78092:;14</01! ..(5! *! %(,! &.(&!*!.(6! &.(&!*!.(6! &.(&!*!.(6!
=4>0;10! -%(+! *! %(-! -+(&!*!,(%! %,,(,!*!,(%! +%()!*!,(%!
$?4<@</0123410! &(6! *! ,(-! .)(+!*!,(6! .)(+!*!,(6! .)(+!*!,(6!
$;?4A;82:! 6(%! *! ,(&! %,,(,!*!,(-! %,,(,!*!,(-! %,,(,!*!,(-!
A.)*"<C'$)'.>*;',
B2CD2?921! %-6()! *! %(+! -&(.!*!5(.!! ''(-!*!5(.! ''(-!*!5(.!
A.)"'+%*.)*&,
E0F2:;D4C! %,(.! *! ,(6! %,,(,!*!,(6! 5(%!*!,(6! -,(.!*!,(6!
A.)*7DE,
G21;9;>;10! -%(+! *! -(+! %,,(,!*!,()! %,,(,!*!,()! +)(5!*!,()!
F#+&*(%,F"#..'+,G+/&H'$>,
H;C9;230:! 5-('! *! ,(.! %,,(,!*!,(%! %,,(,!*!,(%! %,,(,!*!,(%!
I4?F0?2<2:;C! %'(.! *! ,(-! ,(,!*!%(&! .%(-!*!%(&! +()!*!%(&!
B0?2<2:;C! %&(5! *! ,(-! %,,(,!*!,(6! %,,(,!*!,(6! +,(.!*!,(6!
A.)*@*/)*&>,
=;<?4JC4A28;1! -.)&('! *! ))+(+! '+()!*!%(-! &%(,!*!%(-! 5&(6!*!%(-!
KLM! )+)%(5! *! %.-(&! ',(6!*!,('! &5(6!*!,('! 5%(6!*!,('!
73;9/?4:@8;1! 6+5(.! *! 5-(,! +'(&!*!,(&! +&(.!*!,(&! +)('!*!,(&!
NOM! %6'()! *! )(.! +6(,!*!,(&! +6(.!*!,(&! +)(.!*!,(&!
=C2?;9/?4:@8;1! .6(+! *! %(&! +6(+!*!,(-! %,,(,!*!,(-! 5)(5!*!,(-!
#GO! 5.()! *! '(6! +%(%!*!,(5! %,,(,!*!,(5! .'(.!*!,(5!
A.)*C+#)'+'),=$(4,
=C4<;>?4P0C! %%(%! *! ,(-! %,,(,!*!,(%! %,,(,!*!,(%! %,,(,!*!,(%!
F/.)$#>),%'=*(%,
Q4<?4:;>0! 5+,(6! *! 5-()! 5.(+!*!6(6!! %,,(,!*!6(6! %,,(,!*!6(6!
2*($')*&>,
RS#! 5,.(6! *! +(-! ++(%!*!%(%! -'(%!*!%(%! #,
LT?4D0:;>0! -6&(,! *! %,(,! .'(.!*!.(6! )5(5!*!.(6! .%(.!*!.(6!
!><&"*#)$*&,=$(4>,
=;92C4<?2:! )+6(5! *! %-(-! +%('!*!,(&! 5.(+!*!,(&! 5)(%*!,(&!
B01C2J2A;10! )--(%! *! .(.! &&('!*!,(-! 5('!*!,(-! #,
E4?230<2:! '5('! *! )(,! %,,(,!*!%(+! 55(,!*!%(+! -'(5!*!%(+!
=US! &&(+! *! )(%! 5+(,!*!,(5! #, #,
#?234>410! -5(%! *! %(-! %,,(,!*!,(5! %,,(,!*!,(5! %,,(,!*!,(5!
KC2132<;10! %5(-! *! %(&! %,,(,!*!,()! %,,(,!*!,()! .+(&!*!,()!
I/)#+J, %,V%6%(6! *! 6.5(%! !
38 PhACs detected at ini>al >me (11 BQL)
[10,152 ± 574 ng·∙L-‐1] 5 PhACs showed
nega>ve elimina>on rate
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
RESULTS
!"#$%#&'()*&#+,-.*)*#+,&/.&'.)$#)*/.,
0,,12,3.456789,
:'%/;#+,<*'+=>,3?9,@!
!"#$%&'()*+,-()./&)+$#"*/(/#"-0+
!"#$%&'()*+,"#"1-()./&)+$#"*/(/#"-0+
2#"1/"#$%&'()*+,"#"1-()./&)+$#"*/(/#"-0+
A.#+4'>*&>,#.=,#.)*7*.B+#%%#)/$<,=$(4>,
"#$! %&'()! *! +(,! -+()!*!-(%! .'(.!*!-(%! #,
$/0123410! ''(,! *! 5()! 56(,!*!%(%! #, #,
78092:;14</01! ..(5! *! %(,! &.(&!*!.(6! &.(&!*!.(6! &.(&!*!.(6!
=4>0;10! -%(+! *! %(-! -+(&!*!,(%! %,,(,!*!,(%! +%()!*!,(%!
$?4<@</0123410! &(6! *! ,(-! .)(+!*!,(6! .)(+!*!,(6! .)(+!*!,(6!
$;?4A;82:! 6(%! *! ,(&! %,,(,!*!,(-! %,,(,!*!,(-! %,,(,!*!,(-!
A.)*"<C'$)'.>*;',
B2CD2?921! %-6()! *! %(+! -&(.!*!5(.!! ''(-!*!5(.! ''(-!*!5(.!
A.)"'+%*.)*&,
E0F2:;D4C! %,(.! *! ,(6! %,,(,!*!,(6! 5(%!*!,(6! -,(.!*!,(6!
A.)*7DE,
G21;9;>;10! -%(+! *! -(+! %,,(,!*!,()! %,,(,!*!,()! +)(5!*!,()!
F#+&*(%,F"#..'+,G+/&H'$>,
H;C9;230:! 5-('! *! ,(.! %,,(,!*!,(%! %,,(,!*!,(%! %,,(,!*!,(%!
I4?F0?2<2:;C! %'(.! *! ,(-! ,(,!*!%(&! .%(-!*!%(&! +()!*!%(&!
B0?2<2:;C! %&(5! *! ,(-! %,,(,!*!,(6! %,,(,!*!,(6! +,(.!*!,(6!
A.)*@*/)*&>,
=;<?4JC4A28;1! -.)&('! *! ))+(+! '+()!*!%(-! &%(,!*!%(-! 5&(6!*!%(-!
KLM! )+)%(5! *! %.-(&! ',(6!*!,('! &5(6!*!,('! 5%(6!*!,('!
73;9/?4:@8;1! 6+5(.! *! 5-(,! +'(&!*!,(&! +&(.!*!,(&! +)('!*!,(&!
NOM! %6'()! *! )(.! +6(,!*!,(&! +6(.!*!,(&! +)(.!*!,(&!
=C2?;9/?4:@8;1! .6(+! *! %(&! +6(+!*!,(-! %,,(,!*!,(-! 5)(5!*!,(-!
#GO! 5.()! *! '(6! +%(%!*!,(5! %,,(,!*!,(5! .'(.!*!,(5!
A.)*C+#)'+'),=$(4,
=C4<;>?4P0C! %%(%! *! ,(-! %,,(,!*!,(%! %,,(,!*!,(%! %,,(,!*!,(%!
F/.)$#>),%'=*(%,
Q4<?4:;>0! 5+,(6! *! 5-()! 5.(+!*!6(6!! %,,(,!*!6(6! %,,(,!*!6(6!
2*($')*&>,
RS#! 5,.(6! *! +(-! ++(%!*!%(%! -'(%!*!%(%! #,
LT?4D0:;>0! -6&(,! *! %,(,! .'(.!*!.(6! )5(5!*!.(6! .%(.!*!.(6!
!><&"*#)$*&,=$(4>,
=;92C4<?2:! )+6(5! *! %-(-! +%('!*!,(&! 5.(+!*!,(&! 5)(%*!,(&!
B01C2J2A;10! )--(%! *! .(.! &&('!*!,(-! 5('!*!,(-! #,
E4?230<2:! '5('! *! )(,! %,,(,!*!%(+! 55(,!*!%(+! -'(5!*!%(+!
=US! &&(+! *! )(%! 5+(,!*!,(5! #, #,
#?234>410! -5(%! *! %(-! %,,(,!*!,(5! %,,(,!*!,(5! %,,(,!*!,(5!
KC2132<;10! %5(-! *! %(&! %,,(,!*!,()! %,,(,!*!,()! .+(&!*!,()!
I/)#+J, %,V%6%(6! *! 6.5(%! !
3 removal behaviours Inoculated cultures led to lower drug concentra>on (13 PhACs) Inoculated and non-‐inoculated cultures got the same final drug concentra>on (8 PhACs) Non-‐inoculated cultures led to lower drug concentra>on (2 PhACs)
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Non-‐spiked bioslurry at Erlenmeyer scale
RESULTS
!"#$%#&'(&)"#*+(#,%*-#,./012*
3#)&)(4*!"#$%#&'(&)"#*5*67*
-#,./012*
+%8"9(4*:)%4;<*-=2*!"#$%&'()*+,-()./&)0+
!"#$%&'()*+,1#"2-()./&)0+
1#"2/"#$%&'()*+,1#"2-()./&)0+
3+4+566+ !"!#$%& '& ()(*$)& !#$(& %)$+& ),$(&566+7+3+4+86+ )"($#& '& "*$-& **$(& !,$(& *,$(&
86+7+3+ ,*($!& '& (#$)& !"$!& -"$%& !"$(&9#('&+ -(!*$!& '& -##$%& !"$%& %%$-& )#$,&
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Non-‐spiked bioslurry
RESULTS
Fungi profile Ini>al >me: two main fungal species: F3 & F4
Final >me: microbial diversity of the mixture increased
All fungal bands (except F5) correspond to unknown fungi
Bacterial profile More bands at 15d
Fungi Bacteria
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Non-‐spiked bioslurry at reactor scale Once it was proved that T.versicolor could
degrade PPCPs at real concentraPons from MBR sludge without external nutrients and under non-‐
sterile condiPons… The aim was to eliminate drugs from MBR sludge at reactor scale and use the resul4ng biosolids as substrate of an Anaerobic Diges4on
RESULTS
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Bioreactor Performance: Fungus ac4vity
RESULTS
Evalua>on of the fungus state through the laccase ac>vity
Maximum: 14.5 U·∙L-‐1 at day 2
No further oxida>ve poten>al a{er 5d
Non-‐spiked bioslurry at reactor scale
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Bioreactor Performance: PPCPs removal
RESULTS
Non-‐spiked bioslurry at reactor scale
Raw MBR sludge
Fungal bioslurry (5d)
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Bioreactor Performance: PPCPs removal
RESULTS
Non-‐spiked bioslurry at reactor scale
* Removals not assesse due to final concentra>on was higher than ini>al
Total removal: 40.0%
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Anaerobic Bach Assays: inoculum screening
RESULTS
Non-‐spiked bioslurry at reactor scale
Terrassa Sabadell
Blanes !"#$%&%'( )*+(,$$%'%&,+*-(
'*+.,"*(/'0(1234,(
5*+.,"#6*"7$(8$+797+:(;61<=123>6??@AB>-ABC(
;0123>6??@A
B>-ABC!!"##$%%$& !"#$%&%'"()% ("(()% ("((*(
'$($)"**& +","% ("-')% ("(#(%+*$,"%& -$-"*!%&%-*"!#% ("()!% ("(*-%
,(./+01+23,24/+%5,6718%&%82,+9,39%133/3%
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Anaerobic Bach Assays: BMP test Once the inoculums from Sabadell’s and Blanes’ ADs were chosen, the biogas produc>on of the fungal bioslurry was evaluated R
ESULTS
Non-‐spiked bioslurry at reactor scale
Inoculum + fungal
bioslurry of MBR
Experimental Inoculum +
fungal biomass
Fungal Control
Inoculum + fungal
biomass + raw MBR sludge
Sludge Control
VT: 1L VW: 0.6L
[VS]: 3gVS·∙L-‐1
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
RESULTS
Non-‐spiked bioslurry at reactor scale
Sabadell Blanes
Anaerobic Bach Assays: BMP test
Fungal controls showed the higher biogas produc>ons Sludge controls and experimental cultures had similar net biogas produc>on un>l day 10 (sta>onary phase) Some inhibitory product was produced during the fungal bioslurry
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
RESULTS
Non-‐spiked bioslurry at reactor scale
Anaerobic Bach Assays: BMP test The fungus alone (fungal controls) produced high
amounts of biogas When MBR sludge was added (sludge controls) the
produc>on decreased (increasing complexity of the matrix)
The biogas produc>on was inhibited or slowed with the biosolids from the bioslurry (experimental)
Culture Sabadell* Blanes*
Experimental 53.06 ± 8.32 61.71 ± 19.71
Fungal Control 289.51 ± 19.68 126.30 ± 0.00
Sludge Control 100.35 ± 4.16 87.08 ± 9.44
* Net accumulated biogas (mL)
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Anaerobic Bach Assays: Total PPCPs removal PhACs at real concentra>on was monitored for AD
cultures with Blanes’ inoculum in order to…
Evaluate if AD process improved the removal of drugs
RESULTS
Non-‐spiked bioslurry at reactor scale
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
Anaerobic Bach Assays: Total PPCPs removal
RESULTS
Non-‐spiked bioslurry at reactor scale
!"#$"%&'!(&)*)+,-
!"&./&*0+*)"&-1&2345678!
9/#":+,-+;*/0-
8)"<,%00=-1>7.-
9/#":+,-1>7.!!"#$%&!$'()*+,$-$
./$ &01'()223$-$./$
"#$%&'()%*#! +,-+.!/!0-0,! 12-3!/!,-,! 00-4!/!,-,! +1-1!/!,-,-
5%)(%6%$#7'8#! 23-92!/!.-.9! 02-3!/!3-4- +- +!5:;7'<);=#:! 4-+.!/!3-33! ,33-3!/!3-3! +- ,33-3!/!3-,$5;<#'8#! 4>-33!/!.-.9! 10-4!/!3-0! +.-3!/!3-0! 14-,!/!3-0!?'%$#7%6! >3-4+!/!0-0,! 43-3!/!3-3- +- +!@;)%$#7%6! >+-19!/!0-0,! +3-+!/!,-+! 92-3!/!,-2! 19-3!/!,-2!AB#8%$;8#! 0,-9.!/!0-0,! +- +- +!A');C'D%6! 3! +- +- +!A)%E%F*%*'8! ,,3-1,!/!0-0,! 4>-2!/!0-.- +- ,0-,!/!0-.!GH:&%6#*B;C%$;:#! 12-22!/!9-90! .4->!/!3-1! 42-3!/!3-1! ,33-3!/!3-1!I;)%F#6'<#! +-3.!/!3-33! +! ,33-3!/!3-3! ,33-3!/!3-3!
!"#$%&'()"*$%+& ,-.-&/&-.0& ,1.,&/&-.2& 34.4&/&5.-&+!J#6;E%:!8;*!%FF#FF#<K!&'8%:!D;8D#8*)%*';8!L%F!B'=B#)!*B%8!*B#!'8'*'%:!
8!5;8D#8*)%*';8!E%:H#F!/!F*%8<%)<!<#E'%*';8F!.!M));)F!#C7)#FF#<!%F!*B#!<#*#D*';8!:'6'*!;&!#%DB!D;67;H8<!<'E'<#<!(N!0&
!
REMOVAL OF PHARMACEUTICAL PRODUCTS IN BIOSLURRY SYSTEMS
The low solids content of the sludge makes difficult to assess whether the solid or the liquid were treated
MBR sludge can be treated with T.versicolor at laboratory scale, removing a wide range of emerging pollutants
The fungus has grown under non-‐sterile condi>ons without any extra nutrients
Fungal treatment of MBR sludge has been proved as an adequate pre-‐treatment prior anaerobic diges>on, although it slowed the AD process
CONCLUSIONS
!
POST-‐TREATMENT OF WWTP EFFLUENT
!POST-‐TREATMENT OF WWTP EFFLUENT
1. Introduc>on 2. Methodology 3. Results
Substrate Selec>on Total drugs removal Microbial community evolu>on
!POST-‐TREATMENT OF WWTP EFFLUENT
Global popula>on increase leads to a growing demand of water Groundwater is an important natural resource that can be use to supply water for municipal, agricultural, and industrial purposes
Ar>ficial recharge methods are faster than natural systems: - Direct aquifer injec>on systems: to put water directly into the underground water basins
- Surface spreading recharge systems: to replenish aquifers by infiltra>on
INTRODUCTION
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil-‐Aquifer Treatment (SAT) Surface spreading: reclaimed wastewater is intermiaently introduced into spreading basins Water percolates across the ground and throughout the aquifer
Water quality improvement thanks to physical, chemical, and biological natural processes
INTRODUCTION
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil-‐Aquifer Treatment (SAT)
INTRODUCTION
Miotlinski et al. 2010
!POST-‐TREATMENT OF WWTP EFFLUENT
INTRODUCTION
!
Alice Springs SAT Arid Zone Research Ins>tute (Alice Springs, NT, Australia)
Aquifer recharge: 600ML·∙y-‐1
Recharge area: 10,269m3 (5 basins) Infiltra>on rate: 240mm·∙d-‐1
!POST-‐TREATMENT OF WWTP EFFLUENT
Adsorp4on of pollutants The mass transfer of a substance from a liquid to a solid’s surface Ac>vated carbon is the universal adsorbent, but it is expensive
Local materials u>lized as inexpensive sorbents: Low-‐cost sorbents (low processing & abundant) - NUA: neutralised used acid from heavy mineral processing
- BIOCHAR: charcoal produced by the pyrolysis of biomass (eucalyptus)
INTRODUCTION
!POST-‐TREATMENT OF WWTP EFFLUENT
Aim…
Determine if it was possible to treat a WWTP effluent with low-‐cost sorbents in order to use
it in a soil-‐aquifer treatment
INTRODUCTION
!POST-‐TREATMENT OF WWTP EFFLUENT
METHODOLOGY
Soil’s adsorp>on capacity
Amendment ra>o
Removal of PPCPs
PhACs adsorpNon
24 hours
Soil: amendment
raNo
Adsorp>on
24 hours
Spiked drugs removal
Adsorp>on
21 days
!POST-‐TREATMENT OF WWTP EFFLUENT
Soils adsorp4on capacity & Soil:amendment ra4o
METHODOLOGY
Soil from Alice Springs’ SAT (basin E)
0.1M CaCl2
10rpm 12h
PhACs 10rpm / 24h
PhACs quan>fica>on
Adsorp>on
NUA
Biochar
Ra4os: 0.1, 0.5, 1, 2 & 5% w/w
Triplicates &
Sta>s>c analysis
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal in amended soils
METHODOLOGY
Soil from Alice Springs’ SAT (basin E)
0.1M CaCl2
10rpm 12h
PhACs 21d
PhACs quan>fica>on
Removal
NUA
Biochar
1% w/w
Triplicates &
Sta>s>c analysis
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil’s adsorp4on Determine soil’s natural adsorp4on capacity of PPCPs under experimental condi>ons Spiked drugs selected according to reclaimed wastewater characterisa>on studies: Ibuprofen Carbamazipine Sulfamethoxazole Propranolol Ketoprofen Trimethoprim Ofloxacin
RESULTS
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil’s adsorp4on Kd: equilibrium constant isoterm of adsorp>on
- Linear rela>onship between sorbed & non-‐sorbed spices
- Aaenua>on mechanisms & environmental factors are considered
RESULTS
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil’s adsorp4on
RESULTS
Compound Kd (mL·∙g-‐1) ± SD
Ketoprofen 1.21 ± 0.03
Ibuprofen 4.24 ± 0.02
Carbamazepine 2.25 ± 0.05
Sulfamethoxazole 4.38 ± 0.03
Propranolol 22.88 ± 0.01
Trimethoprim 14.46 ± 0.02
Ofloxacin 2487.9 ± 0.4
!POST-‐TREATMENT OF WWTP EFFLUENT
Selec4on of the amendment ra4o Once the natural adsorpPon of the soil was
determined… Removal of PPCPs was studied for both Biochar and NUA, in order to establish the best ra4o of soil:amendment
Ra>os: 0.1, 0.5, 1, 2 & 5 % Three PhACs: Sulfamethoxazole, propranolol & trimethoprim
RESULTS
!POST-‐TREATMENT OF WWTP EFFLUENT
RESULTS
Trimethoprim
RaNo (%) NUA + Sand NUA + Soil Biochar + Sand Biochar + Soil
0.1 2.92 ± 0.44 13.42 ± 0.35 0 3.12 ± 0.17
0.5 * 10.37 ± 0.33 * 1.31 ± 0.58
1 0.37 ± 0.30 13.42 ± 0.23 0 2.09 ± 0.11
2 0.88 ± 0.39 9.45 ± 0.09 0.43 ± 0.32 1.46 ± 0.49
5 0.48 ± 0.21 11.60 ± 0.03 * 1.83 ± 0.10 *Kd value not assessed, measured concentra>on was higher than the ini>al
[mL·∙g-‐1] (± standard error)
Selec4on of the amendment ra4o
!POST-‐TREATMENT OF WWTP EFFLUENT
RESULTS
Propranolol
RaNo (%) NUA + Sand NUA + Soil Biochar + Sand Biochar + Soil
0.1 2.69 ± 0.04 18.44 ± 0.12 8.74 ± 0.30 14.06 ± 0.27
0.5 5.23 ± 0.04 18.38 ± 0.03 11.48 ± 1.02 24.52 ± 0.27
1 3.76 ± 0.29 17.53 ± 0.04 17.11 ± 0.04 15.81 ± 0.07
2 5.47 ± 0.13 17.68 ± 0.10 39.39 ± 0.13 28.54 ± 0.14
5 9.59 ± 0.29 40.17 ± 0.04 39.81 ± 0.31 33.42 ± 0.07
[mL·∙g-‐1] (± standard error)
Selec4on of the amendment ra4o
!POST-‐TREATMENT OF WWTP EFFLUENT
RESULTS
Sulfamethoxazole
RaNo (%) NUA + Sand NUA + Soil Biochar + Sand Biochar + Soil
0.1 * 4.83 ± 0.09 34.70 ± 0.08 29.62 ± 0.02
0.5 * 3.76 ± 0.07 36.97 ± 0.00 35.80 ± 0.01
1 * 4.53 ± 0.00 38.85 ± 0.04 44.88 ± 0.03
2 * 4.63 ± 0.04 56.30 ± 0.04 68.35 ± 0.04
5 0 4.55 ± 0.04 181.74 ± 0.14 181.04 ± 0.14 *Kd value not assessed, measured concentra>on was higher than the ini>al
[mL·∙g-‐1] (± standard error)
Selec4on of the amendment ra4o
!POST-‐TREATMENT OF WWTP EFFLUENT
Selec4on of the amendment ra4o Propranolol and trimethoprim beaer removed with biochar
Sulfamethoxazole beaer removed with NUA Ra>o of 1% selected for further experiments: - All the tested compounds were well retained - Higher ra>o Higher opera>onal costs
RESULTS
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal of PhACs from amended soil Once the amendment raPo was selected…
The removal capacity of amended soil with biochar and NUA at 1% was determined Selected PhACs:
Ofloxacin Carbamazipine Sulfamethoxazole Propranolol Ketoprofen Trimethoprim Ibuprofen
RESULTS
Constant fluctuaNons with high errors
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal of PhACs from amended soil
RESULTS
Plots a: Biochar Soil Plots b: NUA Sand
90.7% 77.7% 80.1% 77.8%
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal of PhACs from amended soil
RESULTS
Plots a: Biochar Soil Plots b: NUA Sand
100% 100% 97.6% 85.6%
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal of PhACs from amended soil
RESULTS
Plots a: Biochar Soil Plots b: NUA Sand
97.4% 91.4%
51.1% 51.7%
32.5% 30.6%
!POST-‐TREATMENT OF WWTP EFFLUENT
Removal of PhACs from amended soil In general, higher removals with biochar, but no sta>s>cal differences with NUA
Biochar: 86.2% NUA: 80.7%
Removal order - Biochar: OFX > TRM = PRN > CBZ > KTP > SMX - NUA: OFX > TRM > PRN > CBZ = KTP > SMX
RESULTS
!POST-‐TREATMENT OF WWTP EFFLUENT
Soil could not adsorb the total amount of PhACs
High removal rates for both NUA and biochar as amendments a{er 21d of treatment
A ra>o of 1% (w/w) of amendment was enough to remove the selected compounds
CONCLUSIONS
!
CONCLUDING REMARKS
!CONCLUDING REMARKS
It has been seen that… Fungal biopiles can be made of forestry by-‐products to treat thermal dried sludge, with the fungus surviving more than 22d and accelera>ng the switch of the microbial popula>on
MBR sludge can be treated in a fungal bioslurry system, and the resul>ng biomass can be energe>cally valorised
Low-‐cost sorbents can be applyed into soil in order to treat reclaimed water as part of a soil-‐aquifer treatment
!CONCLUDING REMARKS
It has been demonstrated that… Different WWTP’s streams can be biologically and physically treated in order to remove PhACs
Fungal mediated systems, both liquid and solid, enhanced the removal of PhACs
Low-‐cost sorbents can improve the final effluent of a WWTP by removing PhACs
!CONCLUDING REMARKS
Further research should be done in order to… Increase the scale of the biopiles Select another sludge (rather than MBR sludge)
Study the PPCPs adsorp>on in con>nuous mode and with real reclaimed water
Search new ways to valorise the biomass from the bioremedia>on processess
Establish the environmental an economical feasibility of the treatments
REMOVAL OF PHARMACEUTICALS FROM WWTP STREAMS BY BIOLOGICAL AND PHYSICAL
PROCESSES
Thanks for your aaen>on!